Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4024290017 | Pertuzumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4024291018 | Product containing pertuzumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pertuzumab-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Pertuzumab-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Pertuzumab-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Pertuzumab-containing product in parenteral dose form | Is a | Product containing pertuzumab (medicinal product) | true | Inferred relationship | Some | ||
| Pertuzumab-containing product in parenteral dose form | Has active ingredient | Pertuzumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only pertuzumab in parenteral dose form (medicinal product form) | Is a | True | Pertuzumab-containing product in parenteral dose form | Inferred relationship | Some | |
| Product containing pertuzumab and trastuzumab in parenteral dose form (medicinal product form) | Is a | True | Pertuzumab-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR